How is the brain important for the regulation of appetite?

Saturday, 11 June 2011

0 comments
We know that maintaining energy balance is essential for keeping a healthy weight i.e. for not developing obesity with all its negative consequences on our life expectancy and mental and physical health.

We also know that brain is a key organ which regulates the energy balance.

But what evidence do we have that convinces us that it is specifically the brain that is the key regulator of energy balance?

There are many lines of evidence which establish the brain, in particular the hypothalamus, as the key regulator of energy balance. However, among the most convincing examples are probably genetic studies of some of the most common monogenic causes of human obesity.

These studies link specific proteins to brain circuits responsible for the regulation of energy balance, specifically to the hypothalamic leptin–melanocortin signalling pathway (see the figure).

In this pathway, leptin, which is secreted from the adipose tissue in proportion to the size of the fat deposits, stimulates leptin receptors on proopiomelanocortin (POMC)-expressing neurons in the arcuate nucleus of the hypothalamus (ARC), a key site of central regulation of energy balance. Subsequently, prohormone convertase 1 (PC1) cleaves the POMC protein into α and β melanocyte stimulating hormones (MSHs). MSHs stimulate melanocortin 4 receptors (MC4Rs), expressed exclusively in the brain, to ultimately reduce food intake and increase energy expenditure.

Deficiency in these components of the pathway – namely leptin, leptin receptor (LepR), pro-opiomelanocortin (POMC), prohormone convertase 1 (PC1), melanocyte stimulating hormone (MSH) and melanocortin 4 receptor (MC4R) – result in positive energy balance and consequently in obesity (Montague et al., 1997; Clement et al., 1998; Krude et al., 1998; Jackson et al., 1997; Yeo et al., 1998).


Figure legend: Most common human monogenetic causes of obesity are linked to the brain, supporting the role ot the brain in the regulation of energy balance. Protein deficiencies resulting in human monogenetic obesity are highlighted in red (adapted from Oswald and Yeo, 2007).

Electrophysiology for dummies alias what is fast capacitance, slow capacitance and R-series?

Friday, 10 June 2011

0 comments
As I promised yesterday, some basic electrophysiology knowledge is coming next as I'm currently learning this technique.

Slow capacitance (C-slow)
- can be viewed as the storage of charge in a cellular (in this case neuronal) membrane
- by pressing the ''Auto'' button in PatchMaster, it is subtracted from the recording for a more accurate result
- it is based on the size of the cell, therefore, on the size of the cell's membrane
- therefore, we can't do much about slow capacitance (can't decrease it)
- therefore, scientists focus on decreasing the fast capacitance to improve the recordings

Fast capacitance (C-fast)
- can be viewed as the storage of charge in a pipette (which is used to patch on cells)
- likewise, by pressing the ''Auto'' button in PatchMaster, it is subtracted from the recording for a more accurate result
- can be improved (decreased) by changing the properties of the pipette (e.g. coating the pipette)

R-series
= series resistance
- therefore measured in ohms
- can be viewed as resistance to the flow of current which is measured in the cell and in the contents of the pipette (their contents mix during whole cell patching and that's why we fill the pipette with an intracellular solution, i.e. one that mimicks the contents of the cell)
- on part of the pipette, the flow is blocked by the pipette's diameter; and on part of the cell, the flow is blocked by the contents of the cell such as the nucleus and other organelles
- we try to have the resistance of the tip and the cell as low as possible for ideal recordings

c-Fos as a marker of neuronal activation - pluses & minuses

Thursday, 9 June 2011

0 comments
Yes, I know, c-Fos for the third time! But bear with me because a new exciting topic of electrophysiology will be coming shortly as I'll be learning that technique.

c-Fos or other markers used in our lab?

In our lab, we haven't used any other markers of neuronal activation (despite researching this alternative last year). Other markers crop up in papers from time to time but c-Fos is best established and most widely used in our field and therefore, works best for our purposes.


Still, what are the pluses & minuses of using c-Fos as a marker of neuronal activity?

+ c-Fos marks recently active neurons

+ can be used together with physiology research and immunohistochemistry techniques

+ is best established and most widely used in our field so we can compare our results with other people's results

- it isn't a direct marker of neuronal activity

- some neurons may be acitvated but c-Fos doesn't have to be transcribed and translated i.e. c-Fos isn't in a pathway for all stimuli/responses

- time course of c-Fos expression might differ cell-to-cell and response-to-response so it needs to be established individually for each experiment

Neurons in the brain are like stars in the universe

Wednesday, 8 June 2011

0 comments
At least for me and at least in this youtube video :)

http://www.youtube.com/watch?v=90cj4NX87Yk&feature=related

Also, I like the part where the animation shows the exchange of the ions.

c-Fos peak in the history & alternative markers of neuronal activation

Tuesday, 7 June 2011

0 comments
history of c-Fos as a marker of neuronal activation?
In the scientific literature, c-Fos was for the first time referred to as a marker of neuronal activation in:

1. Dragunow, M. & Faull, R. (1989). The use of c-fos as a metabolic marker in neuronal pathway tracing. Journal of Neurosci Methods, 29(3), 261-265. (paid)

2. Hoffman, G.E., Smith, M.S. & Verbalis, J.G. (1993). c-Fos and Related Immediate Early Gene Products as Markers of Activity in Neuroendocrine Systems. Frontiers in Neuroendocrinology, 14(3), 173-213.

at least as far as I could find in a brief literature search.

alternative markers of neuronal activation?

1. c-Jun
2. pERK
3. NGFI-B
= nerve growth factor IB
- ''the expression of NGFI-B after both routes of administration is indicative of cellular activation within the pPVN in parallel with secretion of ACTH.'' (Ogilvie et al., 1998)

It seems that selecting the best marker of neuronal activation depends on the neuronal population and the response to a particular stimulus studied.

c-Fos (also cFos, cfos)

Monday, 6 June 2011

0 comments
c-Fos (also cFos, cfos)

what it is?
- is a member of immediate early gene family, which contains transcription factors

how it works?
- because cFos is an 'immediate early gene' transcription factor, it is itself made (=transcribed & translated into a protein) 'immediately early' when cell is stimulated/activated by almost any stimulus; transcription factor then means that cFos helps to transcribe (alone or with other proteins) other genes into proteins, which are required by the cell when the cell is activated in response to the particular stimulus

comparison to?
- to a Bible? it is created/written very early on and helps others to get created/converted later on

also of interest?
- it is a proto-oncogene/protein, i.e. a gene/protein which may become an oncogene/protein; proto-oncogenes code for protein which are involved in a cell cycle, cell growth and differentiation

use?
- in neuroscience: used as an indirect marker of neuronal activation because cFos mRNA or cFos protein are upregulated when cell/neuron fires action potentials and marks recent neuronal activity

Would you have a better comparison for the role of c-Fos as a marker of neuronal activity? If yes, please let me know in the comments.

The parabrachial nucleus (BPN) is directly or indirectly affected by serotonin

Friday, 3 June 2011

0 comments
Or in other words that the parabrachial nucleus (BPN) is directly or indirectly affected by serotonin (5-HT) coming from some of the nine serotonin-producing nuclei in the brain.

Off-topic: Of note, serotonin is also produced in the gastrointestinal tract (vast majority of it in the human body in fact) but it doesn't cross the blood brain barrier. And as a result, it doesn't concern us greatly in the brain (though peripheral - non-brain - serotonin may still affect the brain via affarent sensory neuronal pathways).

Details?

By this I mean that the PBN most likely expresses both serotonin 1B and 2C receptors (5-HT1BRs and 5-HT2CRs).

The 5-HT1BR mRNA expression is detected in PBN by in-situ hybridisation histochemistry (ISHH) techniques (Bruinvels et al., 1993). cFos is a member of an immediate early gene family of transcription factors. As such it responds quickly and transiently to a vast range of neuronal stimuli. This allows us to use is as a marker of neuronal activation. Co come back to presence of 5-HT1BR in the BPN, more research shows that administration of a selective 5-HT1BR agonist such as CP-94253 induces cFos-immunoreactivity in the PBN (Lee et al., 1998). This further supports presence of functional 5-HT1BRs in the PBN.

Similarly to the 5-HT1BR, 5-HT2CR mRNA expression is detected in many brain regions including the PBN (Molineaux et al., 1989; Mengod et al., 1990), though the literature is not specific about the specific subdivisions of the nucleus; we know that the PBN is traditionally divided into medial and lateral: the formed composed of medial PBN 'proper' and lateral PBN, the latter composed of external, internal, waist, ventral, dorsal, superior and central. We also know that d-fenfluramine is a serotonin releaser and serotonin re-uptake inhibitor but also that it has affinity for all three serotonin 2 receptor subtypes in the order of 2C > 2B > 2A, i.e. with highest affinity for 5-HT2CR (Knight et al., 2004). Furthermore, d-fenfluramine induces cFos-IR in rat lateral and dorsal PBN. From that we can infer that 5-HT2CR is expressed mostly in the lateral and dorsal subdivisions of the lateral PBN.

This was the long way to support the claim that the PBN most likely expresses both 5-HT1BRs and 5-HT2CRs. We also know that the PBN receives axonal projections from the dorsal raphae (Petrov et al., 1992), which synthetise and secrete serotonin. Therefore, we can propose that the PBN may be directly stimulated by serotonin.

As for the indirect stimulation of the PBN by serotonin, we need to delve into the model of serotonin-mediated anorexia via two distinct populations of neurons in the arcuate nucleus of the hypothalamus (ARC). In the ARC, serotonin activates Gq-coupled 5-HT2CRs on proopriomelanocortin(POMC)-expressing neurons and inhibits Gi-coupled 5-HT1BRs on agouti-related peptide(AgRP)-expressing neurons. The product of POMC, alpha-melanocyte stimulating hormone (alpha-MSH), and AgRP are endogenous ligands of melanocortin 4 receptors (MC4Rs); the former activates and the latter inhibits MC4R-expressing neurons. Therefore, upon serotonin stimulation of the two populations of neurons, the release of alpha-MSH and AgRP can be altered, leading to increased likelihood of activation of MC4R-expressing neurons. This ultimately results in the serotonin-mediated anorexia, i.e. reduction of food intake. We know that MC4Rs are essential (though not necessarily the only) for the effect of serotonin on food intake because the serotonin-induced anorexia is abolished in MC4R-knockout mice as it is for that matter in 5-HT1BR- and 5-HT2CR-knockout mice.

We also know that MC4Rs are expressed widely throughout the central nervous system (CNS) and among other sites also in the PBN (Kishi et al., 2003; Liu et al., 2003; Mountjoy et al., 1994). Furthermore, we know that the ARC projects directly to the PBN (Wu et al., 2008; Bromberger et al., 1998; Moga et al., 1990a&b; Sim et al., 1991). From that we can imply that the PBN can be also indirectly affected by serotonin via the ARC 5-HT1BR- and 5-HT2CR-expressing AgRP and POMC neurons.

Significance?

From previous research, we already know that in the brain serotonin stimulates 5-HT2CRs on POMC neurons in the ARC, which project to the paraventricular nucleus of the hypothalamus (PVH), where they stimulate MC4R-expressing neurons to ultimately reduce food intake and cause weight reduction. But the above things that I learned today have brought the PBN much more into the picture for me, expanding the complexity of the neural pathways that control appetite and body weight.